{"transactions":[{"id":710123,"issuer":{"id":7822,"kind":"organization","name":"Oncotelic Therapeutics, Inc."},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"DIRECTOR AND CMO - TRANS. MED."}}],"security":"Restricted stock Units","published_at":"2026-07-14T20:00:23.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 10, 2026, the reporting person was granted 1,500 restricted stock units (\"RSUs\"), subject to performance and time-based vesting. On vesting each RSU will immediately be settled by delivery of, and each RSU represents the contingent right to receive, one share of the issuer's Series A Convertible Preferred Stock, par value $0.01. Each share of Series A Convertible Preferred Stock, in turn, is convertible into 1,000 shares of the issuer's common stock, par value $0.01 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU's will vest upon (a) achievement of an uplisting of the issuer's common stock to a national securities exchange on or before June 30, 2027 (or such later date as the Board of Directors may approve), subject to the reporting person's continued service for a period of six months following the uplisting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU's will vest upon (a) achievement of an uplisting of the issuer's common stock to a national securities exchange on or before June 30, 2027 (or such later date as the Board of Directors may approve), subject to the reporting person's continued service for a period of six months following the uplisting."}],"balance_after":1500,"derivative":{"exercise_price":0,"underlying":"Series A Preferred Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001493152-26-033169","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/908259/000149315226033169/ownership.xml","form_type":"4"}},{"id":2576520,"issuer":{"id":7822,"kind":"organization","name":"Oncotelic Therapeutics, Inc."},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clin. Ops. Officer"}}],"security":"Stock Options","published_at":"2021-09-08T21:00:50.000Z","date":"2021-09-03","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: (i) 1/5th on September 30, 2021; (ii) 1/5th on December 31, 2021; (iii) 1/5th on March 31, 2022; (iv) 1/5th on June 30, 2022; and (v) 1/5th on September 30, 2022."}],"balance_after":600000,"derivative":{"exercise_price":0.1393,"expiration_date":"2031-09-03","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001493152-21-022219","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/908259/000149315221022219/ownership.xml","form_type":"4"}},{"id":2632527,"issuer":{"id":7822,"kind":"organization","name":"Oncotelic Therapeutics, Inc."},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF CLINICAL OFFICER"}}],"security":"Stock Options","published_at":"2021-07-16T21:39:03.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Stock options granted pursuant to the Issuer's 2015 Equity Incentive Plan, which vest immediately on the date of grant."}],"balance_after":400000,"derivative":{"exercise_price":0.1626,"exercise_date":"2021-07-08","expiration_date":"2031-07-08","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001493152-21-017107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/908259/000149315221017107/ownership.xml","form_type":"4"}},{"id":2632526,"issuer":{"id":7822,"kind":"organization","name":"Oncotelic Therapeutics, Inc."},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF CLINICAL OFFICER"}}],"security":"Series A Convertible Preferred Stock","published_at":"2021-07-16T21:39:03.000Z","date":"2021-03-31","kind":"exercise","acquired":false,"shares":938,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated April 17, 2019, between the Issuer and Oncotelic, Inc., shares of the Issuer's Series A Convertible Preferred Stock (\"Series A Preferred\") held by the reporting person converted into shares of the Issuer's common stock, following a recapitalization by the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated April 17, 2019, between the Issuer and Oncotelic, Inc., shares of the Issuer's Series A Convertible Preferred Stock (\"Series A Preferred\") held by the reporting person converted into shares of the Issuer's common stock, following a recapitalization by the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated April 17, 2019, between the Issuer and Oncotelic, Inc., shares of the Issuer's Series A Convertible Preferred Stock (\"Series A Preferred\") held by the reporting person converted into shares of the Issuer's common stock, following a recapitalization by the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of the Series A Convertible Preferred Stock does not expire."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":938646},"source":{"system":"sec-edgar","filing":"0001493152-21-017107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/908259/000149315221017107/ownership.xml","form_type":"4"}},{"id":2632525,"issuer":{"id":7822,"kind":"organization","name":"Oncotelic Therapeutics, Inc."},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF CLINICAL OFFICER"}}],"security":"Common Stock","published_at":"2021-07-16T21:39:03.000Z","date":"2021-03-31","kind":"exercise","acquired":true,"shares":938646,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated April 17, 2019, between the Issuer and Oncotelic, Inc., shares of the Issuer's Series A Convertible Preferred Stock (\"Series A Preferred\") held by the reporting person converted into shares of the Issuer's common stock, following a recapitalization by the Issuer."}],"balance_after":1137314,"source":{"system":"sec-edgar","filing":"0001493152-21-017107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/908259/000149315221017107/ownership.xml","form_type":"4"}},{"id":3163475,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-04T21:55:44.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vested in full on the grant date, 4/24/2020."}],"balance_after":25000,"derivative":{"exercise_price":0.6,"exercise_date":"2020-04-24","expiration_date":"2030-04-24","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001551986-20-000106","document":"wf-form4_158862932359777.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273213/000155198620000106/wf-form4_158862932359777.xml","form_type":"4"}},{"id":3502139,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-04T23:24:58.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the reporting person of stock options under the Innovate Biopharmaceuticals, Inc. 2012 Omnibus Incentive Plan. These stock options vest in 36 equal monthly installments."}],"balance_after":25000,"derivative":{"exercise_price":1.28,"expiration_date":"2029-05-31","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001551986-19-000070","document":"wf-form4_155969068468241.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273213/000155198619000070/wf-form4_155969068468241.xml","form_type":"4"}},{"id":3506792,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Exercise (Right to Buy)","published_at":"2019-05-31T09:33:15.000Z","date":"2019-05-29","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6.09,"exercise_date":"2012-06-26","expiration_date":"2019-06-26","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-19-033552","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119033552/doc4.xml","form_type":"4"}},{"id":3506791,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-05-31T09:33:15.000Z","date":"2019-05-29","kind":"sale","acquired":false,"shares":42643,"price":7.747,"value":330355.321,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents an open market sale of a portion of the expiring stock options exercised on this Form 4 to satisfy the Reporting Person's payment of the exercise price and the taxes associated with such exercise."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $7.695 to $7.82, inclusive.  The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":29607,"source":{"system":"sec-edgar","filing":"0001209191-19-033552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119033552/doc4.xml","form_type":"4"}},{"id":3506790,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-05-31T09:33:15.000Z","date":"2019-05-29","kind":"exercise","acquired":true,"shares":50000,"price":6.09,"value":304500.0,"ownership":{"direct":true},"balance_after":72250,"source":{"system":"sec-edgar","filing":"0001209191-19-033552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119033552/doc4.xml","form_type":"4"}},{"id":3529777,"issuer":{"id":6807,"kind":"organization","name":"RANGE IMPACT, INC."},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-14T00:01:46.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person's continuous service to the Corporation, 1/2 of the shares subject to the option vest upon shareholder approval\nof an increase in shares of common stock available for issuance under the Corporation's 2012 Stock Incentive Plan and 1/2 of the shares will\nvest 12 months after that date. In the event of death of the Reporting Person, all shares subject to the Option Grant will vest 100%."}],"balance_after":612559,"derivative":{"exercise_price":0.35,"expiration_date":"2029-05-08","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-19-006973","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438943/000149315219006973/ownership.xml","form_type":"4"}},{"id":3557098,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-04-12T18:01:04.000Z","date":"2019-04-11","kind":"sale","acquired":false,"shares":10738,"price":10.67,"value":114574.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018."}],"balance_after":22250,"source":{"system":"sec-edgar","filing":"0001209191-19-024510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119024510/doc4.xml","form_type":"4"}},{"id":3582350,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Exercise (Right to Buy)","published_at":"2019-03-22T19:54:17.000Z","date":"2019-03-21","kind":"exercise","acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13300,"derivative":{"exercise_price":5.05,"exercise_date":"2010-06-18","expiration_date":"2020-04-20","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001209191-19-021093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119021093/doc4.xml","form_type":"4"}},{"id":3582349,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-03-22T19:54:17.000Z","date":"2019-03-21","kind":"sale","acquired":false,"shares":5500,"price":10,"value":55000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018."}],"balance_after":32988,"source":{"system":"sec-edgar","filing":"0001209191-19-021093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119021093/doc4.xml","form_type":"4"}},{"id":3582348,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-03-22T19:54:17.000Z","date":"2019-03-21","kind":"exercise","acquired":true,"shares":5500,"price":5.05,"value":27775.0,"ownership":{"direct":true},"balance_after":38488,"source":{"system":"sec-edgar","filing":"0001209191-19-021093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119021093/doc4.xml","form_type":"4"}},{"id":3640282,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Exercise (Right to Buy)","published_at":"2019-02-22T16:31:55.000Z","date":"2019-02-21","kind":"exercise","acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18800,"derivative":{"exercise_price":5.05,"exercise_date":"2010-06-18","expiration_date":"2020-04-20","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001209191-19-012593","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119012593/doc4.xml","form_type":"4"}},{"id":3640281,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-02-22T16:31:55.000Z","date":"2019-02-21","kind":"sale","acquired":false,"shares":5500,"price":11.63,"value":63965.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018."}],"balance_after":32988,"source":{"system":"sec-edgar","filing":"0001209191-19-012593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119012593/doc4.xml","form_type":"4"}},{"id":3640280,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-02-22T16:31:55.000Z","date":"2019-02-21","kind":"exercise","acquired":true,"shares":5500,"price":5.05,"value":27775.0,"ownership":{"direct":true},"balance_after":38488,"source":{"system":"sec-edgar","filing":"0001209191-19-012593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119012593/doc4.xml","form_type":"4"}},{"id":3687441,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Exercise (Right to Buy)","published_at":"2019-01-25T21:27:52.000Z","date":"2019-01-24","kind":"exercise","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24300,"derivative":{"exercise_price":5.05,"exercise_date":"2010-06-18","expiration_date":"2020-04-20","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-19-005455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119005455/doc4.xml","form_type":"4"}},{"id":3687440,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Exercise (Right to Buy)","published_at":"2019-01-25T21:27:52.000Z","date":"2019-01-24","kind":"exercise","acquired":false,"shares":1550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option, representing the right to purchase a total of 30,000 shares of common stock, was granted on July 1, 2010.  The stock option became exercisable as to 7,500 shares on July 1, 2010, 7,500 shares on July 1, 2011, 7,500 shares on July 1, 2012 and 7,500 shares on July 1, 2013."}],"balance_after":0,"derivative":{"exercise_price":3.92,"expiration_date":"2020-07-01","underlying":"Common Stock","underlying_shares":1550},"source":{"system":"sec-edgar","filing":"0001209191-19-005455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119005455/doc4.xml","form_type":"4"}},{"id":3687439,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-01-25T21:27:52.000Z","date":"2019-01-24","kind":"sale","acquired":false,"shares":5700,"price":10.37,"value":59109.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018."}],"balance_after":32988,"source":{"system":"sec-edgar","filing":"0001209191-19-005455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119005455/doc4.xml","form_type":"4"}},{"id":3687438,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-01-25T21:27:52.000Z","date":"2019-01-24","kind":"exercise","acquired":true,"shares":5700,"price":5.05,"value":28785.0,"ownership":{"direct":true},"balance_after":38688,"source":{"system":"sec-edgar","filing":"0001209191-19-005455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119005455/doc4.xml","form_type":"4"}},{"id":3687437,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-01-25T21:27:52.000Z","date":"2019-01-24","kind":"sale","acquired":false,"shares":1550,"price":10.37,"value":16073.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018."}],"balance_after":32988,"source":{"system":"sec-edgar","filing":"0001209191-19-005455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119005455/doc4.xml","form_type":"4"}},{"id":3687436,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-01-25T21:27:52.000Z","date":"2019-01-24","kind":"exercise","acquired":true,"shares":1550,"price":3.92,"value":6076.0,"ownership":{"direct":true},"balance_after":34538,"source":{"system":"sec-edgar","filing":"0001209191-19-005455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119005455/doc4.xml","form_type":"4"}},{"id":3701238,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Exercise (Right to Buy)","published_at":"2019-01-08T17:56:04.000Z","date":"2019-01-07","kind":"exercise","acquired":false,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option, representing the right to purchase a total of 30,000 shares of common stock, was granted on July 1, 2010.  The stock option became exercisable as to 7,500 shares on July 1, 2010, 7,500 shares on July 1, 2011, 7,500 shares on July 1, 2012 and 7,500 shares on July 1, 2013."}],"balance_after":1550,"derivative":{"exercise_price":3.92,"expiration_date":"2020-07-01","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0001209191-19-002885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119002885/doc4.xml","form_type":"4"}},{"id":3701237,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-01-08T17:56:04.000Z","date":"2019-01-07","kind":"sale","acquired":false,"shares":7250,"price":10,"value":72500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018."}],"balance_after":32988,"source":{"system":"sec-edgar","filing":"0001209191-19-002885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119002885/doc4.xml","form_type":"4"}},{"id":3701236,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-01-08T17:56:04.000Z","date":"2019-01-07","kind":"exercise","acquired":true,"shares":7250,"price":3.92,"value":28420.0,"ownership":{"direct":true},"balance_after":40238,"source":{"system":"sec-edgar","filing":"0001209191-19-002885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119002885/doc4.xml","form_type":"4"}},{"id":3739276,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-07T22:21:59.000Z","date":"2018-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the reporting person of stock options under the Innovate Biopharmaceuticals, Inc. 2012 Omnibus Incentive Plan.  These stock options vest in 36 equal monthly installments."}],"balance_after":25000,"derivative":{"exercise_price":2.41,"expiration_date":"2028-12-04","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001551986-18-000070","document":"wf-form4_154422130300003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273213/000155198618000070/wf-form4_154422130300003.xml","form_type":"4"}},{"id":3740427,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Exercise (Right to Buy)","published_at":"2018-12-07T17:26:03.000Z","date":"2018-12-06","kind":"exercise","acquired":false,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option, representing the right to purchase a total of 30,000 shares of common stock, was granted on July 1, 2010.  The stock option became exercisable as to 7,500 shares on July 1, 2010, 7,500 shares on July 1, 2011, 7,500 shares on July 1, 2012 and 7,500 shares on July 1, 2013."}],"balance_after":8800,"derivative":{"exercise_price":3.92,"expiration_date":"2020-07-01","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0001209191-18-061554","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118061554/doc4.xml","form_type":"4"}},{"id":3740426,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-12-07T17:26:03.000Z","date":"2018-12-06","kind":"sale","acquired":false,"shares":7250,"price":12.6,"value":91350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018."}],"balance_after":32988,"source":{"system":"sec-edgar","filing":"0001209191-18-061554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118061554/doc4.xml","form_type":"4"}},{"id":3740425,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-12-07T17:26:03.000Z","date":"2018-12-06","kind":"exercise","acquired":true,"shares":7250,"price":3.92,"value":28420.0,"ownership":{"direct":true},"balance_after":40238,"source":{"system":"sec-edgar","filing":"0001209191-18-061554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118061554/doc4.xml","form_type":"4"}},{"id":3770038,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Exercise (Right to Buy)","published_at":"2018-11-09T18:50:53.000Z","date":"2018-11-08","kind":"exercise","acquired":false,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option, representing the right to purchase a total of 30,000 shares of common stock, was granted on July 1, 2010.  The stock option became exercisable as to 7,500 shares on July 1, 2010, 7,500 shares on July 1, 2011, 7,500 shares on July 1, 2012 and 7,500 shares on July 1, 2013."}],"balance_after":16050,"derivative":{"exercise_price":3.92,"expiration_date":"2020-07-01","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0001209191-18-058024","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118058024/doc4.xml","form_type":"4"}},{"id":3770037,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-11-09T18:50:53.000Z","date":"2018-11-08","kind":"sale","acquired":false,"shares":7250,"price":13.07,"value":94757.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018."}],"balance_after":32988,"source":{"system":"sec-edgar","filing":"0001209191-18-058024","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118058024/doc4.xml","form_type":"4"}},{"id":3770036,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-11-09T18:50:53.000Z","date":"2018-11-08","kind":"exercise","acquired":true,"shares":7250,"price":3.92,"value":28420.0,"ownership":{"direct":true},"balance_after":40238,"source":{"system":"sec-edgar","filing":"0001209191-18-058024","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118058024/doc4.xml","form_type":"4"}},{"id":3889756,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-19T18:46:57.000Z","date":"2018-06-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option shares vested on June 18, 2018.  The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years."}],"balance_after":20000,"derivative":{"exercise_price":19.95,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-038677","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118038677/doc4.xml","form_type":"4"}},{"id":3889755,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-06-19T18:46:57.000Z","date":"2018-06-18","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on the earlier of (1) June 18, 2019 or (2) the date of the company's 2019 Annual Meeting of Stockholders."}],"balance_after":32988,"source":{"system":"sec-edgar","filing":"0001209191-18-038677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118038677/doc4.xml","form_type":"4"}},{"id":4067032,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 Par Value","published_at":"2018-02-12T18:22:13.000Z","date":"2017-02-17","kind":"gift","acquired":false,"shares":6975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to his three adult children, who do not share the reporting person's household.  The reporting person disclaims beneficial ownership of the shares held by his three adult children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or any other purpose."}],"balance_after":22988,"source":{"system":"sec-edgar","filing":"0001209191-18-009346","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118009346/doc5.xml","form_type":"5"}},{"id":4255704,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Exercise (Right to Buy)","published_at":"2017-07-18T18:02:20.000Z","date":"2017-07-17","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option, representing the right to purchase a total of 15,000 shares of common stock, was granted on July 20, 2007.  The stock option became exercisable as to 3,750 shares on July 20, 2007, 3,750 shares on July 20, 2008, 3,750 shares on July 20, 2009, and 3,750 shares on July 20, 2010."}],"balance_after":0,"derivative":{"exercise_price":6.9,"expiration_date":"2017-07-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-045562","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919117045562/doc4.xml","form_type":"4"}},{"id":4255703,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-07-18T18:02:20.000Z","date":"2017-07-17","kind":"tax_withholding","acquired":false,"shares":442,"price":7.53,"value":3328.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by Spectrum to satisfy the Reporting Person's tax withholding obligations.  The shares have not been sold by the Reporting Person or by Spectrum.  The shares have been cancelled by the transfer agent."}],"balance_after":22988,"source":{"system":"sec-edgar","filing":"0001209191-17-045562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919117045562/doc4.xml","form_type":"4"}},{"id":4255702,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-07-18T18:02:20.000Z","date":"2017-07-17","kind":"tax_withholding","acquired":false,"shares":13745,"price":7.53,"value":103499.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by Spectrum to satisfy the Reporting Person's payment of the exercise price.  The shares have not been sold by the Reporting Person or by Spectrum.  The shares have been cancelled by the transfer agent."}],"balance_after":23430,"source":{"system":"sec-edgar","filing":"0001209191-17-045562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919117045562/doc4.xml","form_type":"4"}},{"id":4255701,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-07-18T18:02:20.000Z","date":"2017-07-17","kind":"exercise","acquired":true,"shares":15000,"price":6.9,"value":103500.0,"ownership":{"direct":true},"balance_after":37175,"source":{"system":"sec-edgar","filing":"0001209191-17-045562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919117045562/doc4.xml","form_type":"4"}},{"id":4270670,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-06-29T18:39:29.000Z","date":"2017-06-27","kind":"tax_withholding","acquired":false,"shares":880,"price":7.54,"value":6635.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by Spectrum to satisfy the Reporting Person's tax withholding obligations.  The shares have not been sold by the Reporting Person or by Spectrum.  The shares have been cancelled by the transfer agent."}],"balance_after":22175,"source":{"system":"sec-edgar","filing":"0001209191-17-042386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919117042386/doc4.xml","form_type":"4"}},{"id":4281624,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-15T16:56:26.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the option shares vested on June 13, 2017.  The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years."}],"balance_after":20000,"derivative":{"exercise_price":6.48,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-17-040176","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919117040176/doc4.xml","form_type":"4"}},{"id":4281623,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-06-15T16:56:26.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted shares shall vest on the earlier of (1) June 13, 2018 or (2) the date of the company's 2018 Annual Meeting of Shareholders."}],"balance_after":23055,"source":{"system":"sec-edgar","filing":"0001209191-17-040176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919117040176/doc4.xml","form_type":"4"}},{"id":4281622,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-06-15T16:56:26.000Z","date":"2017-06-13","kind":"tax_withholding","acquired":false,"shares":3523,"price":6.48,"value":22829.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by Spectrum to satisfy the Reporting Person's tax withholding obligations.  The shares have not been sold by the Reporting Person or by Spectrum.  The shares have been cancelled by the transfer agent."}],"balance_after":13055,"source":{"system":"sec-edgar","filing":"0001209191-17-040176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919117040176/doc4.xml","form_type":"4"}},{"id":4365137,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-04-03T06:10:20.000Z","date":"2017-03-29","kind":"grant","acquired":true,"shares":20000,"price":1.34,"value":26800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in 12 equal monthly increments, with the first 1/12th vesting on the first monthly anniversary of the Grant Date pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."}],"balance_after":131500,"derivative":{"exercise_price":1.34,"exercise_date":"2017-04-29","expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-17-003341","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315217003341/form4.xml","form_type":"4"}},{"id":4458226,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 Par Value","published_at":"2017-02-10T14:49:19.000Z","date":"2016-01-15","kind":"gift","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Daughter"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved a gift of securities by the reporting person to his adult daughter who shares the reporting person's household.  The reporting person has an indirect beneficial ownership for purposes of Section 16.  The reporting person disclaims beneficial ownership of the shares held by his adult daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This transaction involved a gift of securities by the reporting person to his adult daughter who shares the reporting person's household.  The reporting person has an indirect beneficial ownership for purposes of Section 16.  The reporting person disclaims beneficial ownership of the shares held by his adult daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or any other purpose."}],"balance_after":6192,"source":{"system":"sec-edgar","filing":"0001209191-17-009454","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919117009454/doc5.xml","form_type":"5"}},{"id":4458225,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 Par Value","published_at":"2017-02-10T14:49:19.000Z","date":"2016-01-15","kind":"gift","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved a gift of securities by the reporting person to his adult daughter who shares the reporting person's household.  The reporting person has an indirect beneficial ownership for purposes of Section 16.  The reporting person disclaims beneficial ownership of the shares held by his adult daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or any other purpose."}],"balance_after":23553,"source":{"system":"sec-edgar","filing":"0001209191-17-009454","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919117009454/doc5.xml","form_type":"5"}},{"id":4458224,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30643,"kind":"person","name":"MAIDA ANTHONY E III","position":1,"cik":"0001273213","reported_name":"MAIDA ANTHONY E III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 Par Value","published_at":"2017-02-10T14:49:19.000Z","date":"2016-01-15","kind":"gift","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to his two adult children, who do not share the reporting person's household.  The reporting person disclaims beneficial ownership of the shares held by his two adult children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or any other purpose."}],"balance_after":23553,"source":{"system":"sec-edgar","filing":"0001209191-17-009454","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919117009454/doc5.xml","form_type":"5"}}]}